Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-23

Clinical Trial Update: A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of Delirium [Phase 3]

View source ↗

Summary

Phase 3 double-blind, randomized trial comparing quetiapine with haloperidol for the treatment of delirium was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • Quetiapine (quetiapine)

Snippet

Sponsor: Chiang Mai University | Conditions: Delirium | Phase 3 | Status: TERMINATED